Browsing Tag
American Association for Cancer Research
7 posts
AACR Annual Meeting 2026: what cancer researchers and pharma professionals need to know before San Diego
AACR Annual Meeting 2026 runs April 17-22 at San Diego Convention Center. Over 7,400 abstracts, six plenaries, AI, CAR T, ADCs and RAS inhibitor data.
Avacta (AVCT) at AACR 2026: What the San Diego data presentations actually mean if you’re holding shares through the trial
Avacta Therapeutics (AIM: AVCT) is presenting two posters at AACR 2026 in San Diego. Here is what investors need to understand about conference data versus clinical trial readouts and which milestones actually move the stock.
Senhwa Biosciences expands CX-5461 into photodynamic therapy as AACR 2026 spotlight raises strategic optionality
Senhwa Biosciences expands CX-5461 into photodynamic therapy. Discover how this dual-mechanism strategy could reshape oncology innovation today.
Antengene deepens oncology ambitions with three next-generation ADC and T-cell engager programs at AACR 2026
Discover how Antengene Corporation Limited’s AACR 2026 oncology presentations could reshape its pipeline strategy and investor outlook. Read the full analysis.
CStone Pharmaceuticals unveils next-generation ADC pipeline at AACR 2025 as it shifts to proprietary innovation model
CStone Pharmaceuticals reveals powerful preclinical ADC data at AACR 2025, fueling investor interest in its next-gen oncology pipeline and IND filing momentum.
Inocras launches MRDVision with ppm-level sensitivity, setting new standard in cancer recurrence detection
Inocras launches MRDVision with ppm-level ctDNA sensitivity, setting a new MRD testing standard—discover how it could transform cancer monitoring today.
Y-mAbs Therapeutics showcases promising CD38-SADA translational pharmacokinetics data at AACR 2025
Find out how Y-mAbs’ CD38-SADA translational pharmacokinetics study at AACR 2025 is advancing next-gen cancer therapies with promising clinical insights.